Circio Holding ASA
Developing circular RNA vector tech and immunotherapies for gene and cell therapies.
CRNA | OL
Overview
Corporate Details
- ISIN(s):
- NO0012858564 (+5 more)
- LEI:
- 5967007LIEEXZXFYNS31
- Country:
- Norway
- Address:
- Vollsveien 19, 1366 Lysaker
- Website:
- https://www.targovax.com/en/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Circio Holding ASA is a biotechnology company developing novel circular RNA (circRNA) and immunotherapy medicines. The company's strategic focus is on its proprietary circRNA vector expression technology, designed to enhance the efficacy and safety of next-generation gene and cell therapies. Circio aims to establish a leading position in deploying circRNA for treating genetic diseases and other difficult-to-treat conditions. Its development platform, circVec, has shown the potential for substantially increased protein expression compared to conventional mRNA-based vectors. The company's pipeline includes both its circRNA gene therapy platform and clinical-stage immune-oncology candidates.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-10-08 07:00 |
ISS
Circio presents comprehensive circVec in vivo data package demonstrating 40-fol…
|
Norwegian | 6.2 KB | ||
| 2025-10-06 12:07 |
Share Issue/Capital Change
Circio Holding ASA: Requested Conversion of Convertible Bonds
|
English | 2.8 KB | ||
| 2025-10-01 16:55 |
Prospectus
Circio Holding ASA Approval and publication of prospectus for potential futur…
|
English | 3.0 KB | ||
| 2025-10-01 07:00 |
Regulatory News Service
Circio to present comprehensive circVec-AAV in vivo data package at ESGCT 2025
|
English | 3.7 KB | ||
| 2025-09-09 09:53 |
Share Issue/Capital Change
Circio Holding ASA: Registration of share capital increase following conversion…
|
English | 2.5 KB | ||
| 2025-09-05 10:29 |
Capital/Financing Update
Circio Holding ASA - Conversion of Convertible Bonds and funding requested unde…
|
English | 4.0 KB | ||
| 2025-08-28 07:00 |
Investor Presentation
Circio presents new circVec-AAV vectors showing up to 40x enhanced activity in …
|
English | 2.9 MB | ||
| 2025-08-28 07:00 |
Interim Report
Circio presents new circVec-AAV vectors showing up to 40x enhanced activity in …
|
English | 836.4 KB | ||
| 2025-08-28 07:00 |
Report Publication Announcement
Circio presents new circVec-AAV vectors showing up to 40x enhanced activity in …
|
English | 7.3 KB | ||
| 2025-08-21 07:00 |
Report Publication Announcement
Circio invites to first half 2025 report and R&D update webcast on 28 August
|
English | 3.9 KB | ||
| 2025-08-04 10:57 |
Capital/Financing Update
Circio Holding ASA Funding requested under additional financing commitment fr…
|
English | 2.6 KB | ||
| 2025-07-04 09:22 |
Share Issue/Capital Change
Circio Holding ASA: Registration of share capital increase following conversion…
|
Norwegian | 2.5 KB | ||
| 2025-06-30 21:49 |
Share Issue/Capital Change
Circio Holding ASA: Requested Conversion of Convertible Bonds
|
English | 2.8 KB | ||
| 2025-06-30 07:00 |
Regulatory News Service
NeoRegen Biotech and Circio advance circular RNA delivery collaboration into in…
|
English | 6.1 KB | ||
| 2025-06-20 11:01 |
Share Issue/Capital Change
Circio Holding ASA: Registration of share capital increase following conversion…
|
Norwegian | 2.6 KB |
Automate Your Workflow. Get a real-time feed of all Circio Holding ASA filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Circio Holding ASA via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
